Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 10 | 2009 | 133 | 1.430 |
Why?
|
| Arnold-Chiari Malformation | 5 | 2015 | 12 | 1.130 |
Why?
|
| Fibroblasts | 7 | 2008 | 93 | 1.090 |
Why?
|
| Cancer Vaccines | 4 | 2012 | 14 | 1.020 |
Why?
|
| Interleukin-2 | 7 | 2008 | 69 | 0.960 |
Why?
|
| Cerebrospinal Fluid | 5 | 2005 | 18 | 0.840 |
Why?
|
| Glioma | 8 | 2009 | 54 | 0.700 |
Why?
|
| Intracranial Pressure | 3 | 2006 | 22 | 0.530 |
Why?
|
| Neoplasms | 3 | 2015 | 261 | 0.520 |
Why?
|
| Syringomyelia | 2 | 2005 | 12 | 0.510 |
Why?
|
| Arachnoid Cysts | 2 | 2005 | 6 | 0.500 |
Why?
|
| Cerebrospinal Fluid Pressure | 2 | 2005 | 4 | 0.500 |
Why?
|
| Antineoplastic Agents | 4 | 2007 | 260 | 0.500 |
Why?
|
| Cerebrovascular Circulation | 2 | 2005 | 43 | 0.460 |
Why?
|
| Vaccines, DNA | 1 | 2012 | 6 | 0.400 |
Why?
|
| Mice | 12 | 2012 | 1683 | 0.400 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 46 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2015 | 1311 | 0.380 |
Why?
|
| Compliance | 3 | 2005 | 7 | 0.360 |
Why?
|
| Mice, Inbred C3H | 6 | 2012 | 36 | 0.360 |
Why?
|
| PPAR gamma | 2 | 2007 | 12 | 0.360 |
Why?
|
| Thiazolidinediones | 2 | 2007 | 14 | 0.350 |
Why?
|
| Decompression, Surgical | 3 | 2005 | 151 | 0.320 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 376 | 0.320 |
Why?
|
| Animals | 12 | 2012 | 4723 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2015 | 48 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 8 | 2007 | 466 | 0.270 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 2 | 0.260 |
Why?
|
| Amyloid beta-Peptides | 2 | 2004 | 328 | 0.260 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 24 | 0.260 |
Why?
|
| Interleukins | 1 | 2005 | 38 | 0.250 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2004 | 8 | 0.250 |
Why?
|
| Third Ventricle | 1 | 2004 | 4 | 0.240 |
Why?
|
| Plaque, Amyloid | 1 | 2004 | 153 | 0.230 |
Why?
|
| Microglia | 1 | 2004 | 132 | 0.220 |
Why?
|
| T-Lymphocytes | 3 | 2012 | 223 | 0.220 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 36 | 0.200 |
Why?
|
| Cell Line, Tumor | 4 | 2009 | 272 | 0.170 |
Why?
|
| Female | 11 | 2015 | 16983 | 0.160 |
Why?
|
| Aging | 2 | 2004 | 1727 | 0.150 |
Why?
|
| Treatment Outcome | 5 | 2008 | 3806 | 0.140 |
Why?
|
| H-2 Antigens | 2 | 2008 | 2 | 0.140 |
Why?
|
| Humans | 14 | 2015 | 30997 | 0.140 |
Why?
|
| Survival Analysis | 3 | 2008 | 320 | 0.140 |
Why?
|
| Transfection | 2 | 2008 | 126 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 9 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2015 | 29 | 0.130 |
Why?
|
| Interferon-gamma | 2 | 2008 | 111 | 0.130 |
Why?
|
| Foramen Magnum | 2 | 2005 | 5 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 36 | 0.130 |
Why?
|
| Cell Line | 2 | 2008 | 305 | 0.130 |
Why?
|
| Immune Evasion | 1 | 2015 | 4 | 0.130 |
Why?
|
| Headache | 1 | 2015 | 43 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2015 | 26 | 0.120 |
Why?
|
| Adult | 6 | 2015 | 8931 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 23 | 0.120 |
Why?
|
| Immune Tolerance | 2 | 2015 | 21 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 158 | 0.110 |
Why?
|
| Cytokines | 2 | 2012 | 351 | 0.100 |
Why?
|
| Time Factors | 4 | 2004 | 1672 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 95 | 0.100 |
Why?
|
| Cell Survival | 2 | 2007 | 164 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 32 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2008 | 28 | 0.080 |
Why?
|
| Brain | 3 | 2008 | 1801 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 19 | 0.070 |
Why?
|
| Male | 6 | 2015 | 16445 | 0.070 |
Why?
|
| CD4 Antigens | 1 | 2008 | 37 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2008 | 86 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 55 | 0.070 |
Why?
|
| Chromans | 1 | 2007 | 2 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 583 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 135 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 45 | 0.070 |
Why?
|
| Manometry | 1 | 2006 | 21 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 2006 | 27 | 0.070 |
Why?
|
| Immunotherapy, Active | 1 | 2006 | 3 | 0.070 |
Why?
|
| Gene Expression | 2 | 2009 | 239 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 246 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 81 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2005 | 662 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2003 | 295 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 22 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 20 | 0.060 |
Why?
|
| Age Factors | 2 | 2006 | 873 | 0.060 |
Why?
|
| Astrocytes | 1 | 2007 | 127 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 20 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2003 | 165 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2005 | 63 | 0.060 |
Why?
|
| Congo Red | 1 | 2004 | 2 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 15 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2004 | 22 | 0.060 |
Why?
|
| Spinal Canal | 1 | 2004 | 15 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2004 | 22 | 0.060 |
Why?
|
| Brain Stem | 1 | 2004 | 25 | 0.060 |
Why?
|
| Skull | 1 | 2004 | 26 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2004 | 79 | 0.060 |
Why?
|
| Cell Count | 1 | 2004 | 98 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2005 | 107 | 0.060 |
Why?
|
| Middle Aged | 3 | 2015 | 10195 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 324 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 261 | 0.060 |
Why?
|
| Melanoma, Experimental | 1 | 2003 | 5 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2003 | 5 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2003 | 29 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 430 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 15 | 0.050 |
Why?
|
| Meningioma | 1 | 2003 | 20 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2003 | 93 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 175 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2003 | 184 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 149 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2002 | 94 | 0.050 |
Why?
|
| Hippocampus | 1 | 2003 | 280 | 0.050 |
Why?
|
| Adolescent | 1 | 2005 | 2401 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 498 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 59 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 18 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 19 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2015 | 1 | 0.030 |
Why?
|
| Valsalva Maneuver | 1 | 2015 | 4 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2015 | 1 | 0.030 |
Why?
|
| Phytochemicals | 1 | 2015 | 4 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2015 | 22 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 79 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 10048 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2009 | 15 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 31 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 37 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 217 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 329 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 13 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 16 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 61 | 0.020 |
Why?
|
| Glucose | 1 | 2007 | 65 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2007 | 54 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 18 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 442 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 144 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 243 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 782 | 0.020 |
Why?
|
| Patient Selection | 1 | 2006 | 246 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 818 | 0.010 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 919 | 0.010 |
Why?
|
| Immunity | 1 | 2003 | 26 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 12 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 14 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 206 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 379 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 287 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 414 | 0.010 |
Why?
|